Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study
- Authors
- Kim, Do Young; Shin, Ho-Jin; Min, Chang-Ki; Eom, Hyeon-Seok; Jung, Jongheon; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Lee, Ji Yun; Byun, Ja Min; Kim, Sung-Hyun; Lee, Ji Hyun; Cho, Hee Jeong; Lee, Sang Min; Do, Young Rok; Park, Sungwoo; Lee, Junglim; Lee, Seung-Shin; Kang, Hye Jin; Park, Young Hoon; Lim, Sung-Nam
- Issue Date
- Sep-2023
- Publisher
- Cancer Media Group
- Citation
- Clinical Lymphoma, Myeloma and Leukemia, v.23, pp S189 - S190
- Indexed
- SCIE
SCOPUS
- Journal Title
- Clinical Lymphoma, Myeloma and Leukemia
- Volume
- 23
- Start Page
- S189
- End Page
- S190
- ISSN
- 2152-2650
2152-2669
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.